Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds
The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR).
The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR).
A JAMA Network study finds COVID-19 mRNA vaccines in pregnant women not only safe but also associated with reduced risks of neonatal cerebral ischemia, intracranial hemorrhage, and mortality, supporting vaccination…
Research indicates a potential link between COVID-19 and an increased risk of new-onset dementia in adults over 60, with the risk being similar to that from other respiratory infections.
A meta-analysis in eClinicalMedicine finds vaccines are safe for pregnant women living with HIV, showing reduced immunogenicity compared to those without HIV but no increase in adverse events, highlighting the…
Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.
Review highlights the potential of AI models in predicting cardiovascular disease risks but emphasizes the need for independent external validation to ensure their clinical applicability.
An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of pregestational diabetes-induced congenital heart disease…
Based solely on driving behavior and head/gaze motion, the newly developed tool recognizes low blood sugar levels.
More than one out of three people have pre-diabetes, characterized by abnormal blood sugar levels not yet in the diabetes range – and yet associated with significant increases in eye,…
A single test to speed up diagnosis of a serious disease in pregnant women does not need to be repeated, new research has found.